| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 25,000 | $24.18 | $604,575.00 | -2.3% | -3.6% | -62.0% | |
| Dec 12, 2022 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 11,080 | $46.75 | $517,990.00 | -11.1% | +1.0% | +18.7% | |
| Dec 12, 2022 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 5,000 | $0.32 | $1,589.50 | +1.1% | -26.8% | +5.4% | |
| Dec 12, 2022 | NXGL Nexgel, Inc. | Stefansky David54 | Director | Buy | 7,500 | $1.44 | $10,824.75 | +27.2% | +1.1% | +65.1% | |
| Dec 12, 2022 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 12,136 | $16.60 | $201,456.73 | -3.5% | -34.8% | -32.5% | |
| Dec 9, 2022 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 41,032 | $46.15 | $1,893,503.70 | -29.2% | +1.8% | +18.9% | |
| Dec 9, 2022 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 7,037 | $16.42 | $115,547.54 | -98.5% | -30.2% | -35.3% | |
| Dec 9, 2022 | ELUT Elutia Inc. | Makes Brigid69 | Director | Buy | 2,000 | $3.65 | $7,300.00 | New | +14.5% | -44.3% | |
| Dec 9, 2022 | CNMD Conmed Corp | Garner Todd W67 | Executive Vice President &CFO | Sell | 4,500 | $89.31 | $401,895.00 | -100.0% | +5.7% | +20.3% | |
| Dec 9, 2022 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 7,037 | $16.42 | $115,547.54 | -96.8% | -30.2% | -35.3% | |
| Dec 9, 2022 | AHCO Adapthealth Corp. | Bunting Daniel | COO - Field Operations | Sell | 115,078 | $21.94 | $2,525,375.20 | -38.5% | -33.1% | -62.0% | |
| Dec 9, 2022 | SONX Sonendo, Inc. | Pudipeddi Vamsi Mohan Raj | Director | Buy | 19,500 | $2.85 | $55,575.00 | +15.0% | - | - | |
| Dec 9, 2022 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 5,000 | $0.30 | $1,498.50 | +1.1% | -15.6% | +17.5% | |
| Dec 9, 2022 | TMDX Transmedics Group, Inc. | Provost Miriam | VP, Global Regulatory Affairs | Sell | 3,613 | $59.00 | $213,167.00 | -12.0% | +31.4% | +24.0% | |
| Dec 8, 2022 | DXCM Dexcom Inc | Flynn Paul R47 | EVP Global Revenue | Sell | 8,988 | $123.50 | $1,110,018.00 | -13.9% | -8.1% | -4.6% | |
| Dec 8, 2022 | CTSO Cytosorbents Corp | Chan Phillip P.56 | Chief Executive Officer | Buy | 5,859 | $1.26 | $7,382.34 | +0.7% | +198.4% | +2.4% | |
| Dec 8, 2022 | IART Integra Lifesciences Holdings Corp | Mosebrook Jeffrey70 | SVP, Fin &Princ Acct Officer | Sell | 279 | $56.22 | $15,684.32 | -3.2% | -4.6% | -27.0% | |
| Dec 8, 2022 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 10,000 | $0.28 | $2,777.00 | +2.3% | -11.0% | +35.5% | |
| Dec 8, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 18,800 | $23.98 | $450,830.78 | -0.6% | +2.3% | -60.4% | |
| Dec 8, 2022 | ELUT Elutia Inc. | Birchview Capital, LP64 | 10% Owner | Buy | 97,261 | $4.09 | $398,229.81 | +1.1% | +17.2% | -47.9% | |
| Dec 7, 2022 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 20,000 | $5.75 | $115,000.00 | +2.4% | +4.1% | -75.3% | |
| Dec 7, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $11.86 | $237,200.00 | -0.3% | -15.7% | -35.4% | |
| Dec 7, 2022 | CTSO Cytosorbents Corp | Chan Phillip P.56 | Chief Executive Officer | Buy | 24,141 | $1.26 | $30,474.82 | +1.4% | +194.6% | +5.4% | |
| Dec 7, 2022 | LNSR Lensar, Inc. | Staab Thomas R II | Chief Financial Officer | Buy | 2,752 | $3.16 | $8,697.46 | +1.0% | -1.9% | -28.5% | |
| Dec 7, 2022 | SYK Stryker Corp | Datar Srikant M.51 | Director | Sell | 1,500 | $239.74 | $359,603.10 | -10.0% | +9.3% | +19.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.